Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid Population - Takeaways - MDSpire

Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid Population

  • By

  • Hillary Samples

  • Sharon Cook

  • Jialiang Hua

  • Peter Treitler

  • Elizabeth M. Stone

  • Jennifer Miles

  • Mark Olfson

  • Stephen Crystal

  • January 13, 2026

  • 0 min

Share

  • 1

    In 2023, over 105,000 drug poisoning fatalities occurred in the U.S., with nearly 80,000 involving opioids.

  • 2

    Acute care settings are crucial for connecting opioid overdose survivors to medication for opioid use disorder (MOUD) treatment.

  • 3

    Post-overdose MOUD initiation is low, with most individuals having prior treatment rather than starting new treatment.

  • 4

    The study utilized national Medicaid claims data from 2014-2019 to analyze MOUD initiation after opioid overdose encounters.

  • 5

    Understanding gaps in post-overdose MOUD receipt is essential for improving treatment engagement among Medicaid patients.

Original Source(s)

Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid Population

  • by Hillary Samples, Sharon Cook, Jialiang Hua, Peter Treitler, Elizabeth M. Stone, Jennifer Miles, Mark Olfson, Stephen Crystal

  • January 13, 2026

Related Content

Management algorithm for alcohol withdrawal syndrome, alcohol dependence (AD) and AD with anxiety in the Indian population: a narrative review with expert opinion

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

“You’re Hoping for the Best, but Preparing for the Worst”: Discussions of Starting Buprenorphine in the Context of Fentanyl Use with Clinicians and People Who Use Fentanyl